Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Up 334.8% in January

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 58,271 shares, an increase of 334.8% from the December 31st total of 13,401 shares. Based on an average trading volume of 121,542 shares, the short-interest ratio is currently 0.5 days. Based on an average trading volume of 121,542 shares, the short-interest ratio is currently 0.5 days.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on SAUHY shares. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. UBS Group upgraded Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. The Goldman Sachs Group lowered Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th. Citigroup reissued a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Finally, Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Straumann has a consensus rating of “Hold”.

Straumann Trading Up 2.0%

Shares of SAUHY stock opened at $12.57 on Wednesday. The firm has a fifty day moving average price of $11.94 and a 200 day moving average price of $11.91. Straumann has a 12 month low of $10.30 and a 12 month high of $15.00.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.